Absolutely!! The stock was trading around $0.008 and testing a penny back in June before the CE came on. If there was no CE when they became fully reporting in Sept; this would be over $0.02 now and climbing. You can't fault low volume and low share price when it's almost impossible to buy shares. Every brokerage makes selling (and shorting) easy. But only T Rowe Price is allowing anyone to create positions. As long as the average person can't buy stock in the open market - this will never see true valuations. My prediction: in the next few months they should get the CE off and (hopefully) get rid of the SEC lawsuit. With open buying, we'll easily see $0.03 +. If they actually get the MS studies registered and started - it could be a LOT higher. JMHO- GLTYA